Guidance

Bluetongue serotype 3 vaccine advice for veterinarians

Advice from the UK Chief Veterinary Officer to veterinarians prescribing BTV-3 vaccines.

• From: Department for Environment, Food & Rural Affairs and Veterinary Medicines Directorate
• Published: 16 September 2024

Documents

Advice for veterinarians prescribing BTV-3 vaccines

PDF, 126 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Defra’s Secretary of State has permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom, subject to licence.

Unlike the authorised vaccines for other BTV serotypes, the BTV-3 vaccines claim to reduce viraemia rather than prevent it. This means they may not prevent animals from being infected or infectious, but (depending on the vaccine) their claims include reduction or prevention of clinical signs experienced or mortality.

Veterinarians should read the advisory note before prescribing any BTV-3 vaccine.

As this is the first time that Defra has used this power, the UK Chief Veterinary Officer asks all veterinarians to record all vaccine use and inform relevant authorities of any adverse effects.

For information on how your data is stored see the Exotic, notifiable and reportable diseases privacy notice.

Published 16 September 2024